| Gene symbol | IL3RA | Synonyms | CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | interleukin 3 receptor subunit alpha | ||||
| GTO ID | GTC2338 |
| Trial ID | NCT04318678 |
| Disease | Blastic Plasmacytoid Dendritic Cell Neoplasm | B-Cell Acute Lymphoblastic Leukemia | T-Cell Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia |
| Altered gene | CD123 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD123 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CD123-Directed Autologous T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) |
| Year | 2020 |
| Country | United States |
| Company sponsor | St. Jude Children's Research Hospital |
| Other ID(s) | CATCHAML |
| Cohort 1 | |||||||||||||
|
|||||||||||||